NeuroPed Competitors

Synchron is developing implantable neurotechnology to unlock the brain and solve unmet medical needs at scale

Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease and expects to start pivotal studies in 2022. The company’s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.

We are scientists, researchers, healthcare clinicians, and digital and gaming experts who are passionate about creating new approaches to help people improve their mental health & well-being and become more resilient. With a deep understanding of digital consumer behavior built through years of testing and optimization with 3.5 million users, we’ve designed a global, digital platform, grounded in science, that delivers a dynamic user experience so delightful that building healthier habits feels effortless. Happify Health makes managing mental health & well-being not just possible, but fun.